Diabetic Neuropathy. Type 2 diabetes mellitus with diabetic neuropathy, unspecified
Conditions
Interventions
Intervention 1: Intervention group: The patients of the intervention group use chamomile oil in the base of sesame oil topically twice a day for 3 months. Intervention 2: Control group: Patients in th
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: People over 18 years old with diabetic neuropathy Being treated with routine medications to treat diabetes The patient has controlled diabetes. (In controlled diabetes, the patient's HbA1c is less than 7) Patients should be on gabapentin for diabetic neuropathy The neurothesiometer results should be greater than 15 and less than 25 Having at least reading and writing literacy
Exclusion criteria
Exclusion criteria: The patient does not agree to participate in the study Patients not receiving modern treatment for diabetes or abandoning treatment The patient use other topical, oral or injectable drugs effective on neuropathy The patient has skin allergy The patient have other diseases affecting the results (lumbar disc, sciatica, radiculopathy, peripheral vascular disease, MS, nerve damage diseases such as tarsal tunnel syndrome, etc.). Patients with foot or finger ulcers are excluded from the study due to the distortion of neurosimetry results Use other treatments such as physiotherapy, ultrasound therapy and laser therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity to vibration. Timepoint: Before the intervention, 2 and 3 months after the start. Method of measurement: Neurothesiometer.;Michigan questionnaire score. Timepoint: Before the intervention, 2 and 3 months after the start. Method of measurement: Questionnaire.;DN4 questionnaire score. Timepoint: Before the intervention, 2 and 3 months after the start. Method of measurement: Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting Blood Sugar (FBS). Timepoint: Befor and After intervention. Method of measurement: Blood Test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Amiri
Shiraz University of Medical Sciences
Outcome results
None listed